Scouting report · TNDM
Leigh A. Vosseller
Tandem's CFO since January 2018; joined as VP Finance in 2013
- Born / age
- (53)
- Role
- EVP, Chief Financial Officer & Treasurer
- In the role
- 9 yr
- Education
- BS Missouri State University
- Front Office rank
- not ranked yet
TNDM
Tandem Diabetes Care, Inc.Medtech
- Title
- EVP, Chief Financial Officer & Treasurersrc
- In role
- since 2018-01 (9 yr)
Stake value—no holding or price on file
—thin record
Scouting sheetas of 24 Sep 2026
Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design67revenue, strategic, ebitda, relative tsr, time only · 97.3% for · company lost money
Skin in the game—no holding or price on file
—Hit rate
—Pay at risk
97%Say-on-pay
—Airtime on calls
- Beat
- 0
- Met
- 0
- Missed
- 0
- Withdrawn
- 0
- Still open
- 0
- Answers on calls
- 0
- Questions dodged
- 0
- Dodges / 100 answers
- —
Personal and ownership data
What to weigh
Red flag 1
- The CFO reports to her domestic partner, the CEO. It is disclosed and controlled (compensation committee sets both packages, audit committee added controls), but the two financial-reporting certifiers share a householdsrc
Watch 2
In their favour 1
- Stock ownership guideline is 1x salary; the proxy says all executives complied or were within the phase-in, and she bought shares in the open market in 2025src
Pay
Salary and otherBonus, stock, options, incentive
The table
- Bonus pays on
- Cash bonus, target 60% of salary: 80% worldwide revenue vs $1.054bn target, 10% product launches, 10% customer satisfaction KPI; paid 87% of target
- Long-term award pays on
- 2025 LTI half PSUs (50% FY2027 adjusted EBITDA margin, 50% 2025-27 TSR percentile vs the Russell 3000) and half RSUs over 36 months; May 2026 Form 4 grant was RSUs onlysrc
- Pay at risk not on file
- Pays on returns revenue, strategic, ebitda, relative tsr, time only
- Shareholder vote 97.3% for
- Pay vs profit company lost money
Career
- 2018 – nowTandem Diabetes Caresrc
EVP, Chief Financial Officer & Treasurer (EVP since June 2018)
Also responsible for information technology. Salary raised from $345,000 to $386,250 effective 2018-06-18 (8K-2018-06-15) - 2018 – 2018
- 2017 – 2017
- 2013 – 2017
- 2011 – 2013
- 2008 – 2011Genoptix, Inc.src
Finance roles before becoming CFO (titles not stated)
Before Genoptix she held a senior finance position at Biosite Incorporated, helping build its infrastructure for international expansion; years not stated
Not located: Months of the 2013 move from Genoptix to Tandem not stated; the Biosite years and anything earlier not located in any source searched
The promise ledger
No promise on the record yet: the research routine has not scored this company's guidance.
Background
- Family She and the CEO, John Sheridan, are in a personal relationship and share a primary residence; disclosed since the 2019 CEO succession. She reports to him, neither sets the other's pay, and the audit committee added internal controlssrc
- Giving Director and treasurer of Girls Inc. of San Diego, a non-profit running STEM programmes for underserved girls, since January 2021src
- Legal Named defendant with the CEO in Lowe v. Tandem Diabetes Care (S.D. Cal., filed 2023-09-08) over 2022 sales trends and forecasts; dismissed with prejudice on 2024-06-04 after the plaintiffs did not amendsrc
- Other The proxy reports no Item 401(f) legal proceedings for any director or executive officersrc
Sources11
- Filing Tandem Diabetes Care DEF 14A (accession 0001438133-26-000034) · 2026-04-07
- Filing Tandem Diabetes Care DEF 14A (accession 0001564590-18-009319) · 2018-04-26
- Filing Tandem Diabetes Care 8-K Items 5.02/5.07, CFO salary increase (0001564590-18-015708) · 2018-06-15
- Filing Tandem Diabetes Care 8-K Items 2.02/5.02, CEO succession plan and family-relationship disclosure (0001564590-19-004461) · 2019-02-26
- Filing Tandem Diabetes Care 8-K Items 3.03/5.02/5.07, 2026 annual meeting results (0001438133-26-000070) · 2026-05-21
- Filing Tandem Diabetes Care 10-Q for Q3 2024, Note on legal matters (0001438133-24-000201) · 2024-11-06
- Filing SEC XBRL companyconcept us-gaap/NetIncomeLoss, CIK 1438133 (FY2025 10-K, 0001438133-26-000010) · 2026-02-19
- Filing Form 4, Leigh A. Vosseller (reporting CIK 1726322), open-market purchase of 2025-08-08 (0001438133-25-000163) · 2025-08-11
- Filing Form 4, Leigh A. Vosseller, RSU grant of 2026-05-29 (0001438133-26-000111) · 2026-06-02
- Filing Form 4, Leigh A. Vosseller, RSU vesting and tax withholding of 2026-08-15 (0001438133-26-000132) · 2026-08-18
- Call transcript TNDM Q2 2026 earnings call (2026-08-06), market data